HARP Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Notice: This stock is marked as potentially delisted. It may not be actively trading.

Insider Ownership Percentage: 17.00%

Insider Buying (Last 12 Months): $492,135,715.00

Insider Selling (Last 12 Months): $0.00

Harpoon Therapeutics Insider Trading History Chart

Harpoon Therapeutics Share Price & Price History

^$23.01

+0.30 (1.20%)

As of 03/11/2024 01:00 AM ET

Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!

From Priority Gold | Ad

Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.

Click here for your free guide

Harpoon Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/11/2024	Merck & Co., Inc.	Major Shareholder	Buy	21,397,205	$23.00	$492,135,715.00	1,000
3/23/2023	Ronald Hunt	Director	Buy	1,000	$10,000.00	$10,000,000.00	1,000
9/22/2021	Georgia Erbez	CFO	Buy	1,030	$81.00	$83,430.00
7/1/2021	Holger Wesche	Insider	Sell	1,000	$140.00	$140,000.00	6,285
6/1/2021	Ansbert Gadicke	Major Shareholder	Sell	1,849	$204.40	$377,935.60
5/28/2021	Ansbert Gadicke	Major Shareholder	Sell	1,388	$211.20	$293,145.60
5/26/2021	Ansbert Gadicke	Major Shareholder	Sell	319	$200.40	$63,927.60
5/24/2021	Ansbert Gadicke	Major Shareholder	Sell	500	$201.20	$100,600.00
5/21/2021	Ansbert Gadicke	Major Shareholder	Sell	1,090	$202.10	$220,289.00
5/19/2021	Ansbert Gadicke	Major Shareholder	Sell	1,783	$203.90	$363,553.70
5/17/2021	Ansbert Gadicke	Major Shareholder	Sell	466	$200.70	$93,526.20
5/14/2021	Ansbert Gadicke	Major Shareholder	Sell	690	$200.40	$138,276.00
5/12/2021	Ansbert Gadicke	Major Shareholder	Sell	2,968	$205.30	$609,330.40
5/10/2021	Ansbert Gadicke	Major Shareholder	Sell	1,713	$218.00	$373,434.00
5/4/2021	Impact Fund (Cayman) Oncology	Major Shareholder	Sell	32,851	$224.80	$7,384,904.80
4/29/2021	Impact Fund (Cayman) Oncology	Major Shareholder	Sell	13,014	$219.90	$2,861,778.60

Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!

From Priority Gold | Ad

Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.

Click here for your free guide

SEC Filings (Institutional Ownership Changes) for Harpoon Therapeutics (NASDAQ:HARP)

74.01% of Harpoon Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Harpoon Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/15/2024	Blackstone Inc.	815,000	$9.27M	0.0%	N/A	4.813%
2/14/2024	Commodore Capital LP	1,500,000	$17.06M	1.5%	N/A	8.859%
2/14/2024	New Leaf Venture Partners L.L.C.	1,859,168	$21.14M	17.0%	+489.0%	10.982%
2/9/2024	Franklin Resources Inc.	1,492,368	$16.97M	0.0%	+1,027.8%	8.815%
1/31/2024	abrdn plc	25,991	$0.30M	0.0%	N/A	0.154%
11/15/2023	Kennedy Capital Management LLC	52,987	$0.21M	0.0%	-90.0%	1.366%
11/14/2023	MPM Bioimpact LLC	319,670	$1.29M	0.3%	-90.0%	8.239%
11/13/2023	Acadian Asset Management LLC	7,670	$29K	0.0%	-90.0%	0.198%
8/8/2023	Sequoia Financial Advisors LLC	63,955	$45K	0.0%	-36.0%	0.199%
8/7/2023	Acadian Asset Management LLC	76,710	$53K	0.0%	-32.5%	0.239%
5/8/2023	Bailard Inc.	63,200	$47K	0.0%	N/A	0.168%
5/1/2023	CM Wealth Advisors LLC	50,354	$29K	0.0%	N/A	0.134%
4/25/2023	Sequoia Financial Advisors LLC	100,000	$74K	0.0%	+66.7%	0.267%
2/13/2023	Levin Capital Strategies L.P.	330,000	$0.24M	0.0%	N/A	0.997%
11/15/2022	Piper Sandler & CO.	580,815	$0.56M	0.5%	N/A	1.754%
11/14/2022	Ergoteles LLC	70,054	$68K	0.0%	-23.8%	0.212%
9/16/2022	Federated Hermes Inc.	132,791	$0.25M	0.0%	+45.0%	0.401%
8/12/2022	Franklin Resources Inc.	1,324,504	$2.53M	0.0%	-20.4%	4.003%
5/20/2022	International Biotechnology Trust PLC	151,445	$2.77M	0.6%	-29.6%	0.458%
5/13/2022	Tekla Capital Management LLC	259,910	$1.29M	0.0%	N/A	0.786%
5/12/2022	Connor Clark & Lunn Investment Management Ltd.	14,872	$74K	0.0%	-37.0%	0.045%
2/15/2022	Sender Co & Partners Inc.	14,252	$0.11M	0.1%	N/A	0.044%
2/15/2022	Kennedy Capital Management Inc.	129,766	$0.98M	0.0%	N/A	0.396%
2/14/2022	Point72 Asset Management L.P.	650,000	$4.91M	0.0%	N/A	1.985%
2/14/2022	GSA Capital Partners LLP	35,266	$0.27M	0.0%	+42.0%	0.108%
2/10/2022	Candriam Luxembourg S.C.A.	809,568	$6.11M	0.0%	+65.4%	2.472%
2/10/2022	Panagora Asset Management Inc.	85,059	$0.64M	0.0%	+113.0%	0.260%
2/10/2022	Connor Clark & Lunn Investment Management Ltd.	23,595	$0.18M	0.0%	+110.2%	0.072%
2/8/2022	Northern Trust Corp	191,251	$1.44M	0.0%	-3.4%	0.584%
1/28/2022	Allspring Global Investments Holdings LLC	4,621	$34K	0.0%	N/A	0.014%
11/16/2021	Schonfeld Strategic Advisors LLC	84,272	$0.67M	0.0%	+41.1%	0.258%
11/16/2021	Squarepoint Ops LLC	14,703	$0.12M	0.0%	N/A	0.045%
11/16/2021	Two Sigma Advisers LP	377,500	$2.98M	0.0%	N/A	1.155%
11/16/2021	Two Sigma Investments LP	406,470	$3.21M	0.0%	N/A	1.244%
11/16/2021	Laurion Capital Management LP	305,954	$2.42M	0.0%	-51.5%	0.936%
11/16/2021	Millennium Management LLC	602,752	$4.76M	0.0%	+994.7%	1.845%
11/15/2021	Cubist Systematic Strategies LLC	45,121	$0.36M	0.0%	+356.9%	0.138%
11/15/2021	Dynamic Technology Lab Private Ltd	23,602	$0.19M	0.0%	N/A	0.072%
11/15/2021	Franklin Resources Inc.	1,131,753	$8.94M	0.0%	-0.5%	3.464%
11/15/2021	GSA Capital Partners LLP	24,838	$0.20M	0.0%	+40.7%	0.076%
11/12/2021	Affinity Asset Advisors LLC	250,000	$1.98M	0.5%	+400.0%	0.765%
11/12/2021	Trexquant Investment LP	29,435	$0.23M	0.0%	N/A	0.090%
11/12/2021	Renaissance Technologies LLC	400,788	$3.17M	0.0%	N/A	1.227%
11/12/2021	Jump Financial LLC	31,200	$0.25M	0.0%	N/A	0.096%
11/12/2021	International Biotechnology Trust PLC	215,000	$1.70M	0.4%	N/A	0.658%
11/12/2021	Geode Capital Management LLC	380,213	$3M	0.0%	+8.0%	1.164%
11/12/2021	Connor Clark & Lunn Investment Management Ltd.	11,225	$89K	0.0%	N/A	0.034%
11/10/2021	Goldman Sachs Group Inc.	87,398	$0.69M	0.0%	-60.8%	0.268%
11/10/2021	Panagora Asset Management Inc.	39,929	$0.32M	0.0%	-49.5%	0.122%
11/10/2021	IndexIQ Advisors LLC	21,491	$0.17M	0.0%	+11.1%	0.066%
11/10/2021	Citigroup Inc.	3,817	$30K	0.0%	-96.4%	0.012%
11/9/2021	Barclays PLC	31,167	$0.25M	0.0%	-13.7%	0.095%
11/9/2021	BlackRock Inc.	1,733,182	$13.69M	0.0%	+1.2%	5.305%
11/8/2021	Summit Global Investments	10,800	$85K	0.0%	N/A	0.033%
11/8/2021	Los Angeles Capital Management LLC	55,476	$0.44M	0.0%	-8.1%	0.170%
11/4/2021	Deutsche Bank AG	11,329	$89K	0.0%	-37.4%	0.035%
11/2/2021	New York State Common Retirement Fund	5,809	$46K	0.0%	-66.5%	0.018%
10/19/2021	Assenagon Asset Management S.A.	94,242	$0.75M	0.0%	N/A	0.288%
9/3/2021	Parametric Portfolio Associates LLC	10,509	$0.15M	0.0%	N/A	0.032%
8/25/2021	Marshall Wace North America L.P.	228,128	$3.16M	0.0%	+2.5%	0.698%
8/18/2021	Ikarian Capital LLC	113,600	$1.58M	0.1%	-57.7%	0.348%
8/17/2021	Logos Global Management LP	800,000	$11.10M	0.9%	+166.7%	2.449%
8/17/2021	Boothbay Fund Management LLC	13,508	$0.19M	0.0%	-57.7%	0.041%
8/16/2021	Nantahala Capital Management LLC	443,247	$6.15M	0.2%	-2.1%	1.357%
8/16/2021	California State Teachers Retirement System	25,860	$0.36M	0.0%	+26.5%	0.079%
8/16/2021	Schonfeld Strategic Advisors LLC	59,724	$0.83M	0.0%	-3.2%	0.183%
8/16/2021	Maven Securities LTD	618,610	$8.46M	0.3%	+375.9%	1.894%
8/16/2021	Charles Schwab Investment Management Inc.	173,102	$2.40M	0.0%	+10.7%	0.530%
8/16/2021	State Street Corp	1,328,368	$18.42M	0.0%	+549.0%	4.066%
8/16/2021	Nuveen Asset Management LLC	117,867	$1.64M	0.0%	+21.4%	0.361%
8/16/2021	Federated Hermes Inc.	128,249	$1.78M	0.0%	+75,787.0%	0.393%
8/16/2021	Goldman Sachs Group Inc.	223,039	$3.09M	0.0%	+404.6%	0.683%
8/13/2021	VR Adviser LLC	512,005	$7.10M	0.9%	N/A	1.567%
8/13/2021	Northern Trust Corp	209,369	$2.90M	0.0%	+17.2%	0.641%
8/13/2021	Affinity Asset Advisors LLC	50,000	$0.69M	0.2%	+150.0%	0.153%
8/13/2021	Laurion Capital Management LP	630,571	$8.75M	0.0%	+45.5%	1.930%
8/13/2021	Franklin Resources Inc.	1,137,505	$15.78M	0.0%	+5.9%	3.482%
8/13/2021	Qube Research & Technologies Ltd	54,029	$0.75M	0.0%	N/A	0.165%
8/13/2021	Geode Capital Management LLC	351,962	$4.88M	0.0%	+19.2%	1.077%
8/13/2021	MPM Asset Management LLC	3,130,267	$43.42M	8.1%	-3.3%	9.581%
8/13/2021	Vanguard Group Inc.	1,255,845	$17.42M	0.0%	+5.7%	3.844%
8/13/2021	MPM Oncology Impact Management LP	3,196,707	$44.34M	7.3%	-18.0%	9.785%
8/13/2021	Bailard Inc.	118,878	$1.65M	0.1%	-9.1%	0.364%
8/13/2021	ProShare Advisors LLC	10,697	$0.15M	0.0%	N/A	0.033%
8/12/2021	XTX Topco Ltd	10,898	$0.15M	0.1%	N/A	0.033%
8/12/2021	Dimensional Fund Advisors LP	94,484	$1.31M	0.0%	+221.5%	0.289%
8/12/2021	JPMorgan Chase & Co.	228,316	$3.17M	0.0%	-4.9%	0.699%
8/12/2021	The Manufacturers Life Insurance Company	12,036	$0.17M	0.0%	N/A	0.037%
8/11/2021	Bank of New York Mellon Corp	46,389	$0.64M	0.0%	+14.2%	0.142%
8/11/2021	BlackRock Inc.	1,713,296	$23.77M	0.0%	+2.7%	5.244%
8/11/2021	Deutsche Bank AG	18,102	$0.25M	0.0%	+16.5%	0.055%
8/11/2021	Panagora Asset Management Inc.	79,079	$1.10M	0.0%	-6.7%	0.243%
8/10/2021	Virtus ETF Advisers LLC	14,488	$0.20M	0.1%	-31.8%	0.045%
8/10/2021	Citigroup Inc.	104,669	$1.45M	0.0%	+704.3%	0.322%
8/10/2021	Rafferty Asset Management LLC	59,549	$0.83M	0.0%	N/A	0.183%
8/5/2021	Rhumbline Advisers	14,560	$0.20M	0.0%	+40.8%	0.045%
8/5/2021	Los Angeles Capital Management LLC	60,336	$0.84M	0.0%	+152.8%	0.186%
8/5/2021	GSA Capital Partners LLP	17,659	$0.25M	0.0%	-27.1%	0.054%
8/4/2021	IndexIQ Advisors LLC	19,339	$0.27M	0.0%	-5.5%	0.059%
8/2/2021	New York State Common Retirement Fund	17,331	$0.24M	0.0%	+64.8%	0.053%

Data available starting January 2016

Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company, engages in the development of a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases in the United States. The company develops tri-specific T cell activating construct (TriTAC) product candidate, including HPN328, which is in Phase I/II clinical trials for the treatment of small cell lung cancer and other Delta-like canonical Notch ligand 3-expressing tumors; and HPN217 that is in Phase I clinical trials for the treatment of multiple myeloma. Its preclinical stage product is HPN601 for the treatment of multiple solid tumor indications. It has a discovery collaboration and license agreement with AbbVie Biotechnology Ltd. to develop and commercialize products that incorporate its proprietary TriTAC platform technology together with soluble T cell receptors. The company was incorporated in 2015 and is headquartered in South San Francisco, California. As of March 11, 2024, Harpoon Therapeutics, Inc. operates as a subsidiary of Merck Sharp & Dohme LLC.

Today's Range

Now: $23.01

$23.01

50 Day Range

MA: $22.89

$22.34

$23.01

52 Week Range

Now: $23.01

$3.11

$23.21

Volume

N/A

Average Volume

1,516,200 shs

Market Capitalization

$389.61 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.11

Who are the company insiders with the largest holdings of Harpoon Therapeutics?: Harpoon Therapeutics' top insider investors include:
Merck & Co, Inc (Major Shareholder)
Ronald Hunt (Director)
Learn More about top insider investors at Harpoon Therapeutics.